Cargando…

Glucose‐6‐Phosphate Regulates Hepatic Bile Acid Synthesis in Mice

It is well established that, besides facilitating lipid absorption, bile acids act as signaling molecules that modulate glucose and lipid metabolism. Bile acid metabolism, in turn, is controlled by several nutrient‐sensitive transcription factors. Altered intrahepatic glucose signaling in type 2 dia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoogerland, Joanne A., Lei, Yu, Wolters, Justina C., de Boer, Jan Freark, Bos, Trijnie, Bleeker, Aycha, Mulder, Niels L., van Dijk, Theo H., Kuivenhoven, Jan A., Rajas, Fabienne, Mithieux, Gilles, Haeusler, Rebecca A., Verkade, Henkjan J., Bloks, Vincent W., Kuipers, Folkert, Oosterveer, Maaike H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859192/ https://www.ncbi.nlm.nih.gov/pubmed/31102537 http://dx.doi.org/10.1002/hep.30778

Ejemplares similares

Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a
por: Lei, Yu, et al.
Publicado: (2020)

Impaired Very‐Low‐Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia
por: Hoogerland, Joanne A., et al.
Publicado: (2021)

Resistance to diet-induced adiposity in cannabinoid receptor-1 deficient mice is not due to impaired adipocyte function
por: Oosterveer, Maaike H, et al.
Publicado: (2011)

Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia
por: Rutten, Martijn G. S., et al.
Publicado: (2023)

Response to Spontaneous Cholemia in C57BL/6 Mice Predisposes to Liver Cancer in NASH
por: Ronda, Onne A.H.O., et al.
Publicado: (2022)

Bile Acid Sequestration via Colesevelam Reduces Bile Acid Hydrophobicity and Improves Liver Pathology in Cyp2c70(−/−) Mice with a Human-like Bile Acid Composition
por: Palmiotti, Anna, et al.
Publicado: (2023)

A human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR activation in mice
por: de Boer, Jan Freark, et al.
Publicado: (2020)

Modulation of Bile Acid Metabolism to Improve Plasma Lipid and Lipoprotein Profiles
por: Zhang, Boyan, et al.
Publicado: (2021)

Low production of 12α-hydroxylated bile acids prevents hepatic steatosis in Cyp2c70(−/−) mice by reducing fat absorption
por: Li, Rumei, et al.
Publicado: (2021)

Gut microbiota depletion aggravates bile acid-induced liver pathology in mice with a human-like bile acid composition
por: Verkade, Esther, et al.
Publicado: (2023)

Hepatic Farnesoid X-Receptor Isoforms α2 and α4 Differentially Modulate Bile Salt and Lipoprotein Metabolism in Mice
por: Boesjes, Marije, et al.
Publicado: (2014)

Glycogen storage disease type 1a is associated with disturbed vitamin A metabolism and elevated serum retinol levels
por: Saeed, Ali, et al.
Publicado: (2020)

Mice with a deficiency in Peroxisomal Membrane Protein 4 (PXMP4) display mild changes in hepatic lipid metabolism
por: Blankestijn, Maaike, et al.
Publicado: (2022)

Hepatocyte-specific glucose-6-phosphatase deficiency disturbs platelet aggregation and decreases blood monocytes upon fasting-induced hypoglycemia
por: La Rose, Anouk M., et al.
Publicado: (2021)

Perinatal exposure to UDCA prevents neonatal cholestasis in Cyp2c70(-/-) mice with human-like bile acids
por: de Vries, Hilde D., et al.
Publicado: (2022)

Cholangiopathy and Biliary Fibrosis in Cyp2c70-Deficient Mice Are Fully Reversed by Ursodeoxycholic Acid
por: de Boer, Jan Freark, et al.
Publicado: (2020)

Increased atherosclerosis in a mouse model of glycogen storage disease type 1a
por: La Rose, Anouk M., et al.
Publicado: (2022)

Hepatic stress associated with pathologies characterized by disturbed glucose production
por: Gjorgjieva, Monika, et al.
Publicado: (2019)

Glucose-6 Phosphate, a Central Hub for Liver Carbohydrate Metabolism
por: Rajas, Fabienne, et al.
Publicado: (2019)

Role of bile acids in inflammatory liver diseases
por: Evangelakos, Ioannis, et al.
Publicado: (2021)

Intestinal Farnesoid X Receptor Modulates Duodenal Surface Area but Does Not Control Glucose Absorption in Mice
por: Yang, Jiufang, et al.
Publicado: (2023)

High Fat Feeding Induces Hepatic Fatty Acid Elongation in Mice
por: Oosterveer, Maaike H., et al.
Publicado: (2009)

Milk cholesterol concentration in mice is not affected by high cholesterol diet- or genetically-induced hypercholesterolaemia
por: Dimova, Lidiya G., et al.
Publicado: (2018)

Identification of the fructose transporter GLUT5 (SLC2A5) as a novel target of nuclear receptor LXR
por: Zwarts, Irene, et al.
Publicado: (2019)

Spontaneous liver disease in wild-type C57BL/6JOlaHsd mice fed semisynthetic diet
por: Ronda, Onne A. H. O., et al.
Publicado: (2020)

Effects of an early life diet containing large phospholipid-coated lipid globules on hepatic lipid metabolism in mice
por: Ronda, Onne A. H. O., et al.
Publicado: (2020)

Modeling Phenotypic Heterogeneity of Glycogen Storage Disease Type 1a Liver Disease in Mice by Somatic CRISPR/CRISPR‐associated protein 9–Mediated Gene Editing
por: Rutten, Martijn G.S., et al.
Publicado: (2021)

Glucotoxicity Induces Glucose-6-Phosphatase Catalytic Unit Expression by Acting on the Interaction of HIF-1α With CREB-Binding Protein
por: Gautier-Stein, Amandine, et al.
Publicado: (2012)

Genetic deletion of hepatic NCOR1 protects from atherosclerosis by promoting alternative bile acid-metabolism and sterol excretion
por: Geiger, Martin, et al.
Publicado: (2023)

Impaired Bile Acid Metabolism and Gut Dysbiosis in Mice Lacking Lysosomal Acid Lipase
por: Sachdev, Vinay, et al.
Publicado: (2021)

Intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia
por: Doktorova, Marcela, et al.
Publicado: (2017)

Absence of gut microbiota reduces neonatal survival and exacerbates liver disease in Cyp2c70-deficient mice with a human-like bile acid composition
por: Sjöland, Wilhelm, et al.
Publicado: (2023)

Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control
por: Peeks, Fabian, et al.
Publicado: (2017)

The hepatocyte IKK:NF-κB axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis
por: Heida, Andries, et al.
Publicado: (2021)

Reply
por: Roscam Abbing, Reinout L.P., et al.
Publicado: (2020)

Male apoE*3‐Leiden.CETP mice on high‐fat high‐cholesterol diet exhibit a biphasic dyslipidemic response, mimicking the changes in plasma lipids observed through life in men
por: Paalvast, Yared, et al.
Publicado: (2017)

Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context
por: Monteillet, Laure, et al.
Publicado: (2018)

Potential of ileal bile acid transporter inhibition as a therapeutic target in Alagille syndrome and progressive familial intrahepatic cholestasis
por: Kamath, Binita M., et al.
Publicado: (2020)

A Systems Analysis of Phenotype Heterogeneity in APOE*3Leiden.CETP Mice Induced by Long-Term High-Fat High-Cholesterol Diet Feeding
por: Paalvast, Yared, et al.
Publicado: (2022)

Potential of therapeutic bile acids in the treatment of neonatal Hyperbilirubinemia
por: van der Schoor, Lori W. E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gn7vr1v44s15ruqnu91d1g56mr